Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 2, 2015, Pages 554-559

  Schmidt, Stefanie C S ^a,b   Jiang, Sizun ^a,b   Zhou, Hufeng ^a,b   Willox, Bradford ^b   Holthaus, Amy M ^b   Kharchenko, Peter V ^c   Johannsen, Eric C ^d   Kieff, Elliott ^a,b   Zhao, Bo ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

BATF; CDKN2A; EBNA3A; IRF4; RUNX3

Indexed keywords

BATF PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 3A; EPSTEIN BARR VIRUS ANTIGEN 3C; INTERFERON REGULATORY FACTOR 4; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; VIRUS PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BATF PROTEIN, HUMAN; CCND2 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; CXCL9 CHEMOKINE; CXCL9 PROTEIN, HUMAN; CYCLIN D2; DNA; EBNA-2 PROTEIN, HUMAN HERPESVIRUS 4; EBNA-3A ANTIGEN; EBNA-3C, EPSTEIN-BARR VIRUS; EBNA-LP PROTEIN, HUMAN HERPESVIRUS 4; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; RBPJ PROTEIN, HUMAN; RUNX3 PROTEIN, HUMAN;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA BINDING; ENHANCER REGION; GENE CONTROL; HISTONE MODIFICATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION ELONGATION; BINDING SITE; CELL LINE; EPSTEIN BARR VIRUS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN GENOME; METABOLISM; ONCOGENE MYC; PATHOGENICITY; PHYSIOLOGY; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS GENOME;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; CELL LINE; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CYCLIN D2; DNA; ENHANCER ELEMENTS, GENETIC; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENES, BCL-2; GENES, MYC; GENES, P16; GENOME, HUMAN; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; INTERFERON REGULATORY FACTORS; PROMOTER REGIONS, GENETIC; VIRAL PROTEINS;

EID: 84920973039     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1422580112     Document Type: Article

References (48)

1. Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1(7335):702-703.
2. Alexander FE, et al. (2000) Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents. Br J Cancer 82(5):1117-1121.
3. Longnecker R, Kieff E, Cohen JI (2013) Epstein-Barr Virus (Lippincott Williams & Wilkins, Philadelphia), 8th Ed, pp 1898-1959.
4. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4(10): 757-768.
5. Maruo S, Johannsen E, Illanes D, Cooper A, Kieff E (2003) Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J Virol 77(19):10437-10447.
6. Maruo S, et al. (2005) Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: Transcriptional regulation through RBP-Jkappa/CBF1 is critical. J Virol 79(16):10171-10179.
7. Tomkinson B, Robertson E, Kieff E (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67(4): 2014-2025.
8. Zhao B, Marshall DR, Sample CE (1996) A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. J Virol 70(7): 4228-4236.
9. Robertson ES, et al. (1995) Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol 69(5):3108-3116.
10. Robertson ES, Lin J, Kieff E (1996) The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol 70(5):3068-3074.
11. Dalbiès-Tran R, Stigger-Rosser E, Dotson T, Sample CE (2001) Amino acids of Epstein- Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation. J Virol 75(1):90-99.
12. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci USA 91(16):7568-7572.
13. Henkel T, Ling PD, Hayward SD, Peterson MG (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265(5168):92-95.
14. Hsieh JJ, Hayward SD (1995) Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268(5210):560-563.
15. Jiang S, et al. (2014) Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc Natl Acad Sci USA 111(1):421-426.
16. Cooper A, et al. (2003) EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J Virol 77(2):999-1010.
17. Cludts I, Farrell PJ (1998) Multiple functions within the Epstein-Barr virus EBNA-3A protein. J Virol 72(3):1862-1869.
18. Hickabottom M, Parker GA, Freemont P, Crook T, Allday MJ (2002) Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J Biol Chem 277(49):47197-47204.
19. Bain M, Watson RJ, Farrell PJ, Allday MJ (1996) Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J Virol 70(4):2481-2489.
20. Knight JS, Lan K, Subramanian C, Robertson ES (2003) Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 77(7):4261-4272.
21. Radkov SA, et al. (1999) Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J Virol 73(7):5688-5697.
22. Chen A, Zhao B, Kieff E, Aster JC, Wang F (2006) EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 80(20):10139-10150.
23. Maruo S, et al. (2006) Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc Natl Acad Sci USA 103(51):19500-19505.
24. Tomkinson B, Kieff E (1992) Second-site homologous recombination in Epstein-Barr virus: Insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection. J Virol 66(2):780-789.
25. Hertle ML, et al. (2009) Differential gene expression patterns of EBV infected EBNA- 3A positive and negative human B lymphocytes. PLoS Pathog 5(7):e1000506.
26. Skalska L, White RE, Franz M, Ruhmann M, Allday MJ (2010) Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog 6(6):e1000951.
27. Maruo S, et al. (2011) Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci USA 108(5):1919-1924.
28. Skalska L, et al. (2013) Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog 9(2):e1003187.
29. Tursiella ML, et al. (2014) Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. PLoS Pathog 10(10):e1004415.
30. Bazot Q, et al. (2014) Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1. Nucleic Acids Res 42(15):9700-9716.
31. Harth-Hertle ML, et al. (2013) Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog 9(9):e1003638.
32. Anderton E, et al. (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: Clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27(4):421-433.
33. Young P, Anderton E, Paschos K, White R, Allday MJ (2008) Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones. J Gen Virol 89(Pt 4):866-877.
34. McClellan MJ, et al. (2013) Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS Pathog 9(9):e1003636.
35. Kharchenko PV, Tolstorukov MY, Park PJ (2008) Design and analysis of ChIP-seq experiments for DNA-binding proteins. Nat Biotechnol 26(12):1351-1359.
36. Landt SG, et al. (2012) ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22(9):1813-1831.
37. Ernst J, et al. (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473(7345):43-49.
38. Zhao B, et al. (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci USA 108(36): 14902-14907.
39. Yap KL, et al. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38(5):662-674.
40. Zhao B, et al. (2003) Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. J Virol 77(10):5639-5648.
41. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ (2001) Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J Virol 75(16):7749-7755.
42. Kheradmand Kia S, et al. (2009) EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. Epigenetics Chromatin 2(1):16.
43. Lee S, et al. (2009) Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: Interaction with RBP-Jkappa regulates TCL1. J Virol 83(23): 12368-12377.
44. Maruo S, et al. (2009) Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc Natl Acad Sci USA 106(11):4419-4424.
45. Aguilo F, Zhou MM, Walsh MJ (2011) Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res 71(16):5365-5369.
46. Waltzer L, Perricaudet M, Sergeant A, Manet E (1996) Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol 70(9):5909-5915.
47. Banerjee S, et al. (2013) The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8. PLoS Pathog 9(5):e1003314.
48. Ochiai K, et al. (2013) Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38(5):918-929.